GlassScriptPhysician profile
Shelly A Seifert
NPI 1245286764
$1,777.44
in general payments reported to CMS, 2019-2025
18 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $287 · 2021: $601 · 2022: $414 · 2023: $76.87 · 2024: $19.61 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $175 · Education: $61.95 · Food and Beverage: $34.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $175.00 |
| Education | $61.95 |
| Food and Beverage | $34.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $464.66 | 2019-2024 | Veozah, Myrbetriq |
| Janssen Pharmaceuticals, INC | $231.80 | 2019-2022 | |
| Amgen INC. | $202.71 | 2019-2025 | Prolia |
| Pfizer INC. | $195.07 | 2019-2021 | |
| Novo Nordisk INC | $168.21 | 2020-2022 | |
| Daiichi Sankyo INC. | $85.91 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.42 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $65.05 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.73 | 2019-2021 | |
| Glaxosmithkline, LLC. | $43.69 | 2020 | |
| Lilly USA, LLC | $39.95 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $35.44 | 2021 | |
| Lundbeck LLC | $33.88 | 2020-2021 | |
| Abbvie INC. | $24.23 | 2021-2022 | |
| Amarin Pharma, INC. | $23.44 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $14.21 | 2021 | |
| Merck Sharp & Dohme LLC | $12.33 | 2022 | |
| Organogenesis INC. | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelly Seifert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.